What Researchers Did
Researchers described a single case where hyperbaric oxygen therapy was used to treat a 6-year-old female with acute lymphoblastic leukemia who developed leukoencephalopathy after chemotherapy and radiation.
What They Found
After starting hyperbaric oxygen therapy, the patient's conscious disturbance gradually improved. One month later, all neurological problems resolved completely, and abnormal findings on her brain magnetic resonance imaging (MRI) also improved.
What This Means for Canadian Patients
While this is only one case, it suggests that hyperbaric oxygen therapy might be a potential treatment option for Canadian children experiencing leukoencephalopathy, especially if started early. This could offer hope for patients facing neurological complications from leukemia treatment.
Canadian Relevance
This study was not conducted in Canada, nor does it involve Canadian authors. Leukoencephalopathy is not a Health Canada-recognized indication for hyperbaric oxygen therapy. No direct Canadian connection identified.
Study Limitations
As a single case report, these findings cannot be generalized to a larger patient population and lack a control group for comparison.